Relay Therapeutics Inc (RLAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -52,412 | -75,305 | N/A | N/A |
| Depreciation Amortization | 3,133 | 350 | N/A | N/A |
| Accounts receivable | -75,000 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -410 | 3,000 | N/A | N/A |
| Other Working Capital | -85,170 | 4,310 | N/A | N/A |
| Other Operating Activity | 107,370 | 1,512 | 0 | 0 |
| Operating Cash Flow | $-102,489 | $-66,133 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | 350,058 | 242,475 | N/A | N/A |
| PPE Investments | -1,931 | -7,982 | N/A | N/A |
| Purchase Of Investment | -266,455 | -553,517 | N/A | N/A |
| Investing Cash Flow | $81,672 | $-319,024 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 426,509 | 613 | N/A | N/A |
| Other Financing Activity | 0 | 4,993 | 0 | 0 |
| Financing Cash Flow | $426,509 | $5,606 | $N/A | $N/A |
| Beginning Cash Position | 42,832 | 422,383 | N/A | N/A |
| End Cash Position | 448,524 | 42,832 | N/A | N/A |
| Net Cash Flow | $405,692 | $-379,551 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -102,489 | -66,133 | N/A | N/A |
| Capital Expenditure | -1,931 | -8,002 | N/A | N/A |
| Free Cash Flow | -104,420 | -74,135 | 0 | 0 |